Sort   by:  
 Page size 
UnknownNeutrophil-to-lymphocyte ratio is a novel predictor of venous thrombosis in polycythemia vera.
Not available
S-EPMC8831521 | biostudies-literature
UnknownClinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients.
Not available
S-EPMC9293196 | biostudies-literature
UnknownDefinition and management of ruxolitinib treatment failure in myelofibrosis.
Not available
S-EPMC4315890 | biostudies-literature
UnknownMomelotinib for myelofibrosis: our 14 years of experience with 100 clinical trial patients and recent FDA approval.
Not available
S-EPMC10948874 | biostudies-literature
UnknownMPL-mutated essential thrombocythemia: a morphologic reappraisal.
Not available
S-EPMC6246562 | biostudies-literature
UnknownChronic neutrophilic leukemia: new science and new diagnostic criteria.
Not available
S-EPMC5811432 | biostudies-literature
UnknownRefractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis (RARS-T): 2017 update on diagnosis, risk-stratification, and management.
Not available
S-EPMC5312971 | biostudies-literature
UnknownChronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management.
Not available
S-EPMC5995129 | biostudies-literature
UnknownNeutrophil-to-lymphocyte ratio as a prognostic indicator of mortality in Polycythemia Vera: insights from a prospective cohort analysis.
Not available
S-EPMC11541874 | biostudies-literature
UnknownResearch trends in essential thrombocythemia from 2001 to 2024: a bibliometric analysis.
Not available
S-EPMC11999923 | biostudies-literature
Sort   by:  
 Page size